Thyromimetics in the Treatment of Metabolic-Dysfunction Associated Steatotic Liver Disease (MASLD)

Chair

Marius N Stan, MD

Mayo Clinic

Thyromimetics in the Treatment of Metabolic-Dysfunction Associated Steatotic Liver Disease (MASLD)

Eveline -- Bruinstroop, MD, PhD

Amsterdam UMC

Chair

Michelle -- Rengarajan, MD, PhD

Massachusetts General Hospital

Cardiovascular consequences and mortality in hyperthyroidism

Kristien -- Boelaert, MD

UNIVERSITY OF BIRMINGHAM